High performance liquid chromatography (HPLC, UHPLC) with DAD, RF, MS/MS detectors
Mass spectrometry (LC-MS/MS)
Gas chromatography GC-MS
Development and validation of bioanalytical methods for the determination of the drug and/or its metabolite/s in a biological matrix in accordance with the EMA/FDA guidelines, completed with a validation report;
Development and validation of bioanalytical methods on HPLC-MS/MS systems for determining such components as:
- Difficult endogenous, reactive or unstable analytes in biological fluids;
- Ultrahigh sensitivity assays with pg/ml lower limits of quantification (LLOQ);
- Analysis of samples in several biological species and matrices;
- Analytes requiring derivatization during sample preparation;
- Analysis of chiral compounds;
Full bioanalytical service offering of PK for small molecules (up to 1000 Da);
Development of analytical methods for the determination of small molecules and endogenous components in dried blood spots (Whatman 903 dbs cards, VAMS);
Analytical supporting in therapeutic drug monitoring;
Drug development supporting and consulting;
Bioanalytical method development supporting and consulting;
Bioanalytical Methods List
The development plans for the Bioanalytical Laboratory include expanding the number of LC-MS/MS systems and complementary analytical equipment, enhancing employee qualifications and implementing proteomic technologies.
If you have any other goals or tasks, please send your inquiry at . and we will carefully analyze it to provide the best possible solution.